Cluster D represented patients with AD characterized by a relatively low inflammatory state which made them distinctive from other clusters due to low serum levels of TH2/severity-related (MDC, PARC and TARC) and eosinophil-related markers (RANTES, eotaxin and eotaxin-3). This evidence concerns the gene CCL22 and Alzheimer disease.